iSpecimen Inc. [NASDAQ: ISPC] surged by $0.44 during the normal trading session on Tuesday and reaching a high of $9.80 during the day while it closed the day at $8.50. The company report on January 4, 2022 that iSpecimen to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022.
iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022. Dr. Ianelli’s corporate presentation will be available on-demand starting Monday, January 10th at 7:00 a.m. ET.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
For more information about the H.C. Wainwright BioConnect Conference, or to schedule a one-on-one meeting with iSpecimen’s management, please contact your H.C. Wainwright representative directly or KCSA Strategic Communications at iSpecimen@kcsa.com.
iSpecimen Inc. stock has also loss -16.01% of its value over the past 7 days. However, ISPC stock has inclined by 54.55% in the 3 months of the year. Over the past six months meanwhile, it has gained 26.87% and gained 8.83% year-on date.
The market cap for ISPC stock reached $82.62 million, with 6.96 million shares outstanding and 6.01 million shares in the current float. Compared to the average trading volume of 5.76M shares, ISPC reached a trading volume of 10323706 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about iSpecimen Inc. [ISPC]:
The Average True Range (ATR) for iSpecimen Inc. is set at 3.13, with the Price to Sales ratio for ISPC stock in the period of the last 12 months amounting to 7.31. The Price to Book ratio for the last quarter was 4.89, with the Price to Cash per share for the same quarter was set at 1.01.
ISPC stock trade performance evaluation
iSpecimen Inc. [ISPC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -16.01. With this latest performance, ISPC shares dropped by -35.80% in over the last four-week period, additionally plugging by 26.87% over the last 6 months .
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ISPC stock in for the last two-week period is set at 42.93, with the RSI for the last a single of trading hit 38.68, and the three-weeks RSI is set at 45.71 for iSpecimen Inc. [ISPC]. The present Moving Average for the last 50 days of trading for this stock 9.83, while it was recorded at 8.44 for the last single week of trading.
iSpecimen Inc. [ISPC]: An insightful look at the core fundamentals
iSpecimen Inc.’s liquidity data is similarly interesting compelling, with a Current Ratio set at 7.10.
iSpecimen Inc. [ISPC]: Insider Ownership positions
There are presently around $7 million, or 10.50% of ISPC stock, in the hands of institutional investors. The top three institutional holders of ISPC stocks are: BLEICHROEDER LP with ownership of 618,180, which is approximately 2.98% of the company’s market cap and around 15.20% of the total institutional ownership; KEPOS CAPITAL LP, holding 225,000 shares of the stock with an approximate value of $1.81 million in ISPC stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $0.22 million in ISPC stock with ownership of nearly New of the company’s market capitalization.
8 institutional holders increased their position in iSpecimen Inc. [NASDAQ:ISPC] by around 91,050 shares. Additionally, 5 investors decreased positions by around 296,073 shares, while 1 investors held positions by with 529,218 shares. The mentioned changes placed institutional holdings at 916,341 shares, according to the latest SEC report filing. ISPC stock had 7 new institutional investments in for a total of 73,161 shares, while 5 institutional investors sold positions of 296,073 shares during the same period.